Industry news

• Within the next two years, every child in Russia battling hepatitis C can to be cured

  19 September 2024 GxP news

  Vladimir Chulanov, the chief freelance specialist in infectious diseases at the Russian Ministry of Health, announced that every child in the Russian Federation diagnosed with hepatitis C has the potential to be completely cured within the next two years. He noted that this opportunity will appear thanks to the Circle of Kindness foundation.

• Sepsis: addressing unmet needs for a global priority

  19 September 2024 Catherine Eckford / European Pharmaceutical Review

  Limited funding and a lack of drugs targeting the root cause of sepsis are some of the current obstacles when addressing the disease burden, GlobalData says.

• 87% of cancer patients give positive ratings for medical care quality

  18 September 2024 GxP news

  During a round table focused on the federal initiative “Fight Against Cancer,” experts examined the outcomes and future possibilities of this significant endeavor. Irina Borovaya, President of the Association of Cancer Patients, highlighted a remarkable rise in patient satisfaction regarding cancer care, soaring from 82% in 2022 to an impressive 87% in 2023.

• The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024

  18 September 2024 GxP news

  RNC Pharma, the analytical firm, has revealed its list of the top 10 best-selling brands of fillers and biorevitalizants in the Russian retail market, showcasing the results from the first and second quarters of 2024. In the first half of 2024, the Russian injection cosmetology market experienced a remarkable growth of 21% compared to the previous year, achieving a volume of 10.9 billion rubles.

• Pharma’s Patient Reach Problem: Billions Still Left Behind

  17 September 2024 Patrick Burton / Pharmaboardroom

  The global pharma industry is facing increased pressure to ensure lifesaving medications reach underserved populations. Drawing from a new Access to Medicine Foundation report, AMF Head of Research Claudia Martinez shares some exclusive insights on where pharma has made significant strides on the important metric of ‘patient reach’ and the road still to travel.

• The Federation Council has proposed simplifying the transfer of patients’ medical data for training AI

  17 September 2024 GxP news

  Artem Sheikin, deputy chairman of the Council for the Development of the Digital Economy of the Federation Council, announced an innovative initiative from senators. They have suggested that the Russian Ministry of Health create a mechanism allowing for automatic consent from patients who receive assistance under the compulsory medical insurance program. This consent would permit the use of their anonymized data for training artificial intelligence (AI).

• The Russian government will support the development and production of modern drugs

  16 September 2024 GxP news

  The Russian government has declared an allocation of 82.3 million rubles to the National Medical Research Center of Hematology, affiliated with the Ministry of Health. According to the press service of the Cabinet of Ministers, this funding will be allocated to enhance the center dedicated to the research and production of cutting-edge high-tech pharmaceuticals. An order to this effect has been signed.

• Russia’s Long-Lasting Flu Vaccine Undergoes Trials

  16 September 2024 GxP news

  The Smorodintsev Research Institute of Influenza, a federal institution under the Russian Ministry of Health, is in the process of creating a long-lasting vaccine against the influenza A virus. This innovative vaccine aims to provide protection against infection for several years. The director of the research institute, Dmitry Lioznov, announced at a conference in Novosibirsk that the drug is now in the preclinical trial phase.

• Moscow to Launch Digitalization Course for Students

  12 September 2024 GxP news

  Sechenov University, also known as the First Moscow State Medical University, has collaborated with leading experts from the capital’s Department of Healthcare to create an innovative educational program aimed at training specialists in digital healthcare. Second-year students and above from both medical and nonmedical disciplines at Sechenov University, as well as students from other Russian universities who have enrolled in the University’s digital department, will have the opportunity to participate in a comprehensive nine-month course.

• Russia has created an oral drug aimed at treating obesity and diabetes

  12 September 2024 GxP news

  Scientists from the Volgograd State Medical University (Vol GMU) have developed an oral drug to combat excess weight and obesity. The medication known as “Dipiaron” is available in capsule form, according to reports from Ivan Tyurenkov, a professor at the Institute of Continuous Medical and Pharmaceutical Education at Volgograd State Medical University.